Several of our Advocate Collaborative members have helped to design an anonymous survey on treatment choices for individuals with HER2+ metastatic breast cancer, regardless of hormone-receptor status, in the US. This study is being conducted by Drs. Adami and Papautsky at the University of Illinois Chicago and patient advocate, and Advocate Collaborative member, Martha Carlson….
Following nearly four years of collaboration, the Advocate Collaborative has made the decision to incorporate as a non-profit organization. This decision was made after careful consideration for the pros and cons of what it means to incorporate and the challenges of seeking support in a challenging advocacy environment. But the facts were instructive. We are…
A huge thank you to all who contributed their experiences and to all who shared with their networks. We shared data from the breast cancer subset of our first advocate-driven research at San Antonio Breast Cancer Symposium last week! Looking forward to publishing in other forums and to sharing the full all-cancers dataset in 2024. #SABCS23.